According to the Secretary General for the Coordination of Vaccinations Fanassis Kontogeorgis, today, Monday, April 5, in Greece, about 60,000 vaccinations will be given for the first time. President of the National Vaccination Committee Maria Theodoridou and Secretary General of Primary Health Care Marios Themistokleous held a regular briefing on the national plan for vaccination against COVID-19. It is noted that the goal is for the total number of vaccinated (at least 1 dose) to exceed 2 million people within a week, and in early May, according to the Secretary General for the Coordination of Vaccination Issues Tanasis Kontogeorgis, we will reach a significant immunity wall. On the issue of replacing the AstraZeneca vaccine, the Pan-Hellenic Pharmaceutical Association said the platform does not provide such an option. In the same announcement, citizens are urged not to come to pharmacies to replace the vaccine. In other words, if you don’t want AstraZeneca, then you won’t get anything. The President of the National Vaccination Committee, Maria Theodorido, gave instructions on early diagnosis and detection of the rare thrombosis syndrome and reiterated that the link to the AstraZeneca vaccine was being studied. The President of the National Vaccination Committee, Professor Maria Feodoridou, spoke about the manifestation of thrombosis and thrombocytopenia syndrome and answered the question of the concern of citizens who believe it is related to the AstraZeneca vaccine, saying that it is more common in women under the age of 55. According to her, cases of the disease occurred in all age groups, while in Greece, out of a total of 346,000 doses of AstraZeneca vaccine, 1 episode was reported in ΕΟΦ, which was identified as possibly related to the drug, and it was included in EMA reports. Ms Theodoridou said that guidelines have been drawn up and will be released tomorrow, Tuesday, for timely information and treatment of the syndrome. In particular, healthcare providers must complete a yellow card if they report cases of thrombosis or thrombocytopenia within 28 days of vaccination. Accordingly, citizens should consult a doctor if, after vaccination, they notice: Shortness of breath. Neurological symptom. A persistent headache for more than four days in a row. Dermatological manifestations outside the vaccination site, such as bruising. As Ms Theodoridou pointed out, the instructions should not cause panic and anxiety, because they are rare cases and are designed to receive correct and timely assistance. For those wondering if they should take aspirin before vaccinations as a precautionary measure, the doctor reiterated that they should not take any anticoagulants unless they are already receiving any appropriate treatment. According to Ms Theodoridou, “Despite concerns about incidents, ΕΜΑ stresses that the proven effectiveness of the vaccine far outweighs the low likelihood of side effects,” and reiterated that the link is being investigated. The professor stressed that the number of episodes of thromboembolism after mass vaccination does not exceed the expected, and that “there is no documented relationship with a previous history of thrombocytopenia or hereditary thrombophilia.” PS One thing is not clear, if the vaccine is so good, why did several leading European countries refuse it? …
Source link
News in English from Greece
More Stories
Secret minutes of RKI meetings during the covid pandemic have been published – about lockdowns, vaccinations and masks
2,000 deaths and 20,000 hospitalizations avoided thanks to self-diagnosis
Will Greek ground forces go to Ukraine?